These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9497015)

  • 1. The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs.
    Mele A; Wozniak KM; Hall FS; Pert A
    Psychopharmacology (Berl); 1998 Jan; 135(2):107-18. PubMed ID: 9497015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801.
    Mele A; Fontana D; Pert A
    Synapse; 1997 Jul; 26(3):218-24. PubMed ID: 9183811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
    Balla A; Koneru R; Smiley J; Sershen H; Javitt DC
    Neuropsychopharmacology; 2001 Aug; 25(2):157-64. PubMed ID: 11425499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.
    Griffiths MR; Cooper AJ; Barber DJ; Mitchell IJ
    Brain Res; 2000 Feb; 855(1):1-10. PubMed ID: 10650124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
    Takahata R; Moghaddam B
    Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor.
    Sircar R; Soliman KF
    Pharmacol Biochem Behav; 2003 Mar; 74(4):943-52. PubMed ID: 12667909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
    Andrés ME; Gysling K; Bustos G
    Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
    Hanania T; Hillman GR; Johnson KM
    Synapse; 1999 Mar; 31(3):229-39. PubMed ID: 10029241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat.
    Griffiths MR; Mitchell IJ; Cooper AJ
    Brain Res; 1999 Mar; 821(1):177-89. PubMed ID: 10064802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.
    Jentsch JD; Tran A; Taylor JR; Roth RH
    Psychopharmacology (Berl); 1998 Jul; 138(1):89-95. PubMed ID: 9694531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.
    Hertel P; Mathé JM; Nomikos GG; Iurlo M; Mathé AA; Svensson TH
    Behav Brain Res; 1995 Dec; 72(1-2):103-14. PubMed ID: 8788863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
    Nishijima K; Kashiwa A; Hashimoto A; Iwama H; Umino A; Nishikawa T
    Synapse; 1996 Apr; 22(4):304-12. PubMed ID: 8867025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW; Bradberry CW; Moghaddam B
    Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
    Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
    Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.